NEDA MOGHADASI: Open Payments
NPI 1659415115 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $111 |
| Boston Scientific Corporation | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Amgen Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: JARDIANCE, Ozempic, OTEZLA, LUX-Dx Insertable Cardiac Monitor, EMBLEM MRI S-ICD, SHINGRIX, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
